Umc Utrecht
Clinical trials sponsored by Umc Utrecht, explained in plain language.
-
New hope for rare nerve disorder: drug combo trial targets mobility
Disease control OngoingThis study tests whether adding zanubrutinib to standard rituximab therapy can improve walking and arm function in people with nerve damage from a blood condition called IgM MGUS. About 35 adults will receive the combination for up to 12 months, with follow-up over 3 years. The g…
Phase: PHASE2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Exercise as medicine: new study targets fatigue in advanced breast cancer
Symptom relief OngoingThis study looks at whether a 9-month, personalized exercise plan can lessen cancer-related fatigue and improve quality of life in 357 people with stage IV breast cancer. Participants follow a structured exercise routine and wear an activity tracker. The goal is to see if exercis…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 17, 2026 01:02 UTC
-
Sound waves vs. bone pain: new combo could replace radiation
Symptom relief OngoingThis study tests if using focused ultrasound (MR-HIFU) alone or with standard radiation can better relieve bone pain caused by cancer that has spread to the bones. About 216 adults with painful bone metastases will receive either ultrasound, ultrasound plus radiation, or radiatio…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 17, 2026 00:59 UTC
-
Pregnancy care goes digital: home monitoring could replace hospital stays
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether women with high-risk pregnancies can safely monitor their baby's heart rate and their own blood pressure from home instead of going to the hospital. About 450 participants across four European hospitals will use certified home devices, with healthcare pro…
Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 17, 2026 00:49 UTC
-
New mesh device aims to quiet stubborn chest pain
Symptom relief ENROLLING_BY_INVITATIONThis study tests a small metal mesh device, called a coronary sinus reducer, in 50 people with chest pain caused by tiny heart vessel disease. The device is placed in a heart vein to increase pressure and improve blood flow. Researchers will measure changes in blood flow and dail…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC